Literature DB >> 6731468

Long-term weight regulation in treated hyperthyroid and hypothyroid subjects.

B J Hoogwerf, F Q Nuttall.   

Abstract

Body weight regulation after treatment was studied in 87 hyperthyroid and 18 hypothyroid subjects. Mean body weight was 83.9 percent of the premorbid weight at the time of initial treatment for hyperthyroidism and 102.5 percent at 96 months following treatment. Mean (+/- SD) post-treatment weight difference from baseline was 3.4 +/- 18.6 pounds at 96 months (n = 44). Early weight gain was greatest in subjects in whom thyroxine values normalized quickly. Hyperthyroid subjects from whom a body mass index could be calculated (n = 45) were divided into two groups. The obese group had a greater mean weight loss (35.2 +/- 15.0 pounds versus 21.2 +/- 9.9 pounds, p less than 0.001) and a lower weight (percent of baseline weight) at the time of treatment for hyperthyroidism (81.6 +/- 7.7 percent versus 86.0 +/- 5.1 percent, p less than 0.05). Subjects with thyroxine levels of 20 micrograms/dl or more had higher premorbid body weights and greater weight loss from baseline than subjects with thyroxine values below 20 micrograms/dl. Hypothyroid subjects showed a small decline in mean body weight over the first six months of treatment but returned to pretreatment weight by 24 months. In the absence of significant metabolic derangement, body weight is regulated within narrow limits over many years. Effective treatment of hyperthyroidism is accompanied by weight gain.

Entities:  

Mesh:

Year:  1984        PMID: 6731468     DOI: 10.1016/0002-9343(84)90842-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism.

Authors:  Ethem Turgay Cerit; Mujde Akturk; Alev E Altinova; Yusuf Tavil; Cigdem Ozkan; Cagri Yayla; Mustafa Altay; Canan Demirtas; Nuri Cakir
Journal:  Endocrine       Date:  2014-10-25       Impact factor: 3.633

Review 2.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

3.  Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial.

Authors:  G Liu; L Liang; G A Bray; L Qi; F B Hu; J Rood; F M Sacks; Q Sun
Journal:  Int J Obes (Lond)       Date:  2017-01-31       Impact factor: 5.095

Review 4.  Thyroid function and obesity.

Authors:  Peter Laurberg; Nils Knudsen; Stig Andersen; Allan Carlé; Inge Bülow Pedersen; Jesper Karmisholt
Journal:  Eur Thyroid J       Date:  2012-09-22

Review 5.  Can body temperature dysregulation explain the co-occurrence between overweight/obesity, sleep impairment, late-night eating, and a sedentary lifestyle?

Authors:  Rhonda F Brown; Einar B Thorsteinsson; Michael Smithson; C Laird Birmingham; Hessah Aljarallah; Christopher Nolan
Journal:  Eat Weight Disord       Date:  2017-09-19       Impact factor: 4.652

6.  Treatment of pediatric Graves' disease is associated with excessive weight gain.

Authors:  Nicole R van Veenendaal; Scott A Rivkees
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

Review 7.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

8.  Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism.

Authors:  David F Schneider; Ratnam Nookala; Taylor J Jaraczewski; Herbert Chen; Carmen C Solorzano; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-02-13       Impact factor: 5.344

9.  Weight gain during the treatment of thyrotoxicosis using conventional thyrostatic treatment.

Authors:  M S Rathi; J N Miles; P E Jennings
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

10.  Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism.

Authors:  Rafael Fazylov; Eliana Soto; Steve Cohen; Stephen Merola
Journal:  Obes Surg       Date:  2008-03-27       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.